Individualized Homoeopathic Management of Polyendocrine Metabolic Ovarian Syndrome with Secondary Infertility: A Case Report

Nilanjana Chattopadhyay; Annapoorani S; Nayak Chintamani; Chattopadhyay Abhijit; Priya Debnath; Halder Tanudipta; Nayana N; Kusumapriya Bandi; Dubey Shikha; Satpathy Shantanu

doi:10.37022/wjcmpr.v8i3.422

Authors

Nilanjana Chattopadhyay Professor and Head, Department of Homoeopathic Materia Medica (P.G.), L. R. Shah Homoeopathy College, Rajkot, Gujarat, India
Annapoorani S Postgraduate Trainee, Department of Materia Medica, National Institute of Homoeopathy, Kolkata, West Bengal, India
Chintamani Nayak Associate Professor and Head, Department of Homoeopathic Materia Medica, National Institute of Homoeopathy, Kolkata, West Bengal, India
Abhijit Chattopadhyay Principal, Tripura Government Homoeopathic Medical College, Tripura, India
Priya Debnath Assistant Professor, Department of Community Medicine, L. R. Shah Homoeopathy College, Rajkot, Gujarat, India
Tanudipta Halder Assistant Professor, Department of Research Methodology and Biostatistics (P.G.), L. R. Shah Homoeopathy College, Rajkot, Gujarat, India
Nayana N Postgraduate Trainee, Department of Materia Medica, National Institute of Homoeopathy, Kolkata, West Bengal, India
Bandi Kusumapriya Postgraduate Trainee, Department of Materia Medica, National Institute of Homoeopathy, Kolkata, West Bengal, India
Shikha Dubey Postgraduate Trainee, Department of Materia Medica, National Institute of Homoeopathy, Kolkata, West Bengal, India
Shantanu Satpathy Postgraduate Trainee, Department of Materia Medica, National Institute of Homoeopathy, Kolkata, West Bengal, India

Abstract

Background

Polyendocrine Metabolic Ovarian Syndrome is an endocrine and reproductive disorder affecting 7 to 15% of women of reproductive age. PMOS is the first cause of anovulatory infertility nowadays and infertility is found in 70 to 80% of affected women. Currently, the most preferred and better serving regimen of PMOS is opting for allopathic medicines; however, considering the side effects, there is a demand for a complementary therapy. Constitutional Homoeopathic medicine acts on psychic, somatic and pathological levels providing holistic approach to cure diseases.

Case Report

A 19-year-old woman presented to the National Institute of Homoeopathy on April 7, 2025, with a clinical history of secondary infertility of two years' duration. Her presentation included associated symptoms of scanty menses, leucorrhea, and headaches. Mentally, she is sensitive to contradiction, fears being alone, and suffers from deep grief regarding her inability to conceive. Ultrasound (USG) showed polycystic ovarian morphology, and blood test indicated a prolactin level of 52.11 ng/ml. This indicates the diagnosis of PMOS with secondary infertility.

Intervention and Outcome

The remedy selected was NATRUM CARBONICUM. The patient was followed up for 12 months. After taking NATRUM CARBONICUM 0/1 to 0/12, her condition improved markedly; USG report showed that the polycystic morphology was resolved and the serum prolactin level came to normal, from 52.11 ng/ml to 19.72 ng/ml. She subsequently became pregnant, confirmed by a positive urine HCG test and a serum beta-HCG level of 95.2 mIU/ml. Modified Naranjo Criteria for Homoeopathy (MONARCH) score was reported as +8.

Conclusion

The case was followed for 12 months with a positive result of pregnancy after individualized homoeopathic treatment. Constitutional homoeopathy was reported to be successful in the treatment of PMOS with secondary infertility.

Keywords:

PMOS, Secondary infertility, Individualized homoeopathic treatment, Natrum carbonicum, Hyperprolactinemia, MONARCH

DOI

https://doi.org/10.37022/wjcmpr.v8i3.422

Author Biography

Abhijit Chattopadhyay, Principal, Tripura Government Homoeopathic Medical College, Tripura, India

Principal, Tripura Government Homoeopathic Medical College, Tripura, India, and Former Director, National Institute of Homoeopathy, Kolkata, West Bengal, India

References

1. Collée J, Mawet M, Tebache L, Nisolle M, Brichant G. Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecol Endocrinol. 2021 Oct;37(10):869-874. doi: 10.1080/09513590.2021.1958310. Epub 2021 Aug 2. PMID: 34338572.

2. Badawei AAB, ALakkad A, Murad R. Correlation of hyperprolactinemia, Subclinical hypothyroidism with Polycystic Ovary Syndrome and infertility. J. Drug Delivery Ther. [Internet]. 2023 Mar. 15 [cited 2026 Sep. 17];13(3):1-4. Available from: https://jddtonline.info/index.php/jddt/article/view/5751

3. Hart R. PCOS and infertility. Panminerva Med. 2008 Dec;50(4):305-14. PMID: 19078871.

4. Aasiya B, Lahanya G, Ishfaq Ahmad B. Comprehension, Management, and Treatment of Polycystic Ovarian Syndrome via Allopathic, Unani and Ayurvedic Perspectives. J Gynecol Women’s Health. 2021: 21(1): 556055. DOI: 10.19080/JGWH.2021.21.556055

5. Parveen S, Das S. Homeopathic Treatment in Patients with Polycystic Ovarian Syndrome: A Case Series. Homeopathy. 2021 Aug;110(3):186-193. doi: 10.1055/s-0041-1725039. Epub 2021 May 12. PMID: 33979843.

6. Rath P. A case of infertility due to PCOS treated successfully with homoeopathy. Int. J. Hom. Sci. 2020;4(2):249-260. DOI: https://doi.org/10.33545/26164485.2020.v4.i2d.174

7. Lane DE. Polycystic ovary syndrome and its differential diagnosis. Obstet Gynecol Surv. 2006 Feb;61(2):125-35. doi: 10.1097/01.ogx.0000197817.93201.04. PMID: 16433936.

8. Synchorne F. Radar. Belgium: Synthesis; 2007. Synthesis Adonis: New Homoeopathy Synthesis Updates: RadarOpus. [Last accessed 22.07.2022].

9. Boericke W. Pocket Manual of Homoeopathic Materia Medica & Repertory: Comprising the Characteristic and Guiding Symptoms of All Remedies (Clinical and Pathogenetic), Including Indian Drugs. B. Jain Publishers; 2002.

10. Allen HC. Allen's Keynotes—Rearranged and Classified. B. Jain Publishers (P) Ltd.; 1999.

11. Kicińska AM, Maksym RB, Zabielska-Kaczorowska MA, Stachowska A, Babińska A. Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome. Biomedicines. 2023 May 28;11(6):1567. doi: 10.3390/biomedicines11061567. PMID: 37371662; PMCID: PMC10295970.

12. Kim SI, Yoon JH, Park DC, Yang SH, Kim YI. What is the optimal prolactin cutoff for predicting the presence of a pituitary adenoma in patients with polycystic ovary syndrome? Int J Med Sci. 2023 Feb 13;20(4):463-467. doi: 10.7150/ijms.80891. PMID: 37057215; PMCID: PMC10087626.

13. Shi YQ, Wang Y, Zhu XT, Yin RY, Ma YF, Han H, Han YH, Zhang YH. The Application of Complementary and Alternative Medicine in Polycystic Ovary Syndrome Infertility. Evid Based Complement Alternat Med. 2022 Oct 7;2022:5076306. doi: 10.1155/2022/5076306. PMID: 36248406; PMCID: PMC9568292.